Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Respiration ; 101(8): 709-716, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35717945

RESUMEN

Advanced chronic obstructive pulmonary disease (COPD) might result in chronic hypercapnic ventilatory failure. Similar to neuromuscular and restrictive chest wall diseases, long-term non-invasive positive pressure ventilation (NPPV) is increasingly used in chronic hypercapnic COPD. This review describes the methods, patient selection, ventilatory strategies, and therapeutic effects of long-term Home-NPPV based on randomized controlled clinical trials published since 1985 in English language retrieved from the databases PubMed and Scopus. Long-term NPPV is feasible and effective in stable, non-exacerbated COPD patients with daytime hypercapnia with arterial pressure of carbon dioxide (PaCO2) levels ≥50 mm Hg (6.6 kPa), if the applied ventilatory pressures and application times improve baseline hypercapnia by at least 20%. Patients who survived an acute hypercapnic exacerbation might benefit from long-term NPPV if hypercapnia persists 2-4 weeks after resolution of the exacerbation. Pressure-controlled ventilation or pressure-support ventilation with adequate minimum backup breathing frequencies, in combination with nasal masks or oronasal masks have been successfully used in all larger clinical trials. Ventilatory strategies with mean inspiratory pressures of up to 28 cm H2O are well-tolerated by patients, but limitations exist in patients with impaired cardiac performance. Home-NPPV with a PaCO2-reductive approach might be considered as an additional treatment option in patients with stable chronic hypercapnic COPD.


Asunto(s)
Ventilación no Invasiva , Enfermedad Pulmonar Obstructiva Crónica , Insuficiencia Respiratoria , Humanos , Hipercapnia/etiología , Hipercapnia/terapia , Ventilación no Invasiva/métodos , Respiración con Presión Positiva/métodos , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/terapia , Insuficiencia Respiratoria/terapia
2.
Pneumologie ; 75(12): 971-980, 2021 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-34233361

RESUMEN

Multidrug-resistant tuberculosis (MDR-TB) is of low proportion in comparison to the total number of TB patients, however, due to the necessity of a complex medication with potentially severe and life threatening adverse reactions, long term sequelae, and unfavorable outcome special attention is essential. We report the case of a 30-year-old geriatric nurse with a history of chronic cough and hereditary alpha-1-anti-trypsin deficiency (AATD), who suffered from MDR-TB and experienced a number of severe adverse reactions.


Asunto(s)
Tos , Tuberculosis Resistente a Múltiples Medicamentos , Adulto , Anciano , Antituberculosos/uso terapéutico , Humanos , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico
3.
Infect Control Hosp Epidemiol ; 41(10): 1209-1211, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32489162

RESUMEN

We investigated potential transmissions of a symptomatic SARS-CoV-2-positive physician in a tertiary-care hospital who worked for 15 cumulative hours without wearing a face mask. No in-hospital transmissions occurred, despite 254 contacts among patients and healthcare workers. In conclusion, exposed hospital staff continued work, accompanied by close clinical and virologic monitoring.


Asunto(s)
Infecciones por Coronavirus/diagnóstico , Transmisión de Enfermedad Infecciosa de Profesional a Paciente , Médicos , Neumonía Viral/diagnóstico , Betacoronavirus/aislamiento & purificación , COVID-19 , Trazado de Contacto , Infecciones por Coronavirus/transmisión , Infección Hospitalaria/transmisión , Infección Hospitalaria/virología , Femenino , Alemania , Hospitales , Humanos , Máscaras , Pandemias , Neumonía Viral/transmisión , SARS-CoV-2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA